T-cell response in penicillin allergy

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 4, 1998, Pages 33-36

  Padovan, E ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

Allergy; Haptens; Penicillin; Penicilloyl peptides; T cell

Indexed keywords

AMINOPENICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; EPITOPE; HAPTEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; PENICILLOIC ACID; PEPTIDE; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; DRUG STRUCTURE; HUMAN; PENICILLIN ALLERGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MODIFICATION; T LYMPHOCYTE ACTIVATION;

ALLERGENS; ANIMALS; DRUG HYPERSENSITIVITY; HUMANS; PENICILLINS; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 0031709858     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Weltzien HU, Moulon C, Martin S et al. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology 1995; 107: 141-51.
2. Batchelor FR, Janet MD, Gazzard D. Penicillin allergy: the formation of the penicilloyl determinant. Nature 1965; 206: 362-4.
3. Levine BB, Redmond AP. Minor haptenic determinant-specific reagents of penicillin hypersensitivity in man. Int Arch Allergy Appl Immunol 1969; 35: 445-9.
4. Brander C, Mauri-Hellweg D, Bettens F et al. Heterogeneous T cell responses to β-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 1995; 155: 2670-80.
5. Hertl M, Merk HF. Lymphocyte activation in coutaneous drug reactions. J Invest Dermatol 1995; 105: 95s-98s.
6. Padovan E, Mauri-Hellweg D, Pichler WJ, Weltzien HU. T cell recognition of penicillin G: structural features determining antigenic specificity. Eur J Immunol 1996; 26: 42-8.
7. Padovan E, Bauer T, Tongio MM, Kalbacher H, Weltzien HU. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 1997; 27: 1303-7.
8. Hammer J, Valsasnini P, Tolba K et al. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 1993; 74: 197-203.
9. McNicoll JM, Withworth WC, Oftung F et al. Structural requirement of peptide and MHC for DR(α,β1*0401)-restricted T cell antigen recognition. J Immunol 1995; 155: 1951-63.
10. Stern LJ, Brown JH, Jardesky TS et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994; 368: 215-21.
11. Verreck FAW, van de Poel A, Drijfhout JW et al. Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, DR11, DR13, and DR52. Immunogenetics 1996; 43: 392-7.
12. Garcia KC, Degano M, Stanfield RL et al. An αβ T cell receptor structure at 2.5Å and its orientation in the TCR-MHC complex. Science 1996; 274: 209-19.